Compare QS & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QS | MMED |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.1B |
| IPO Year | 2020 | 2026 |
| Metric | QS | MMED |
|---|---|---|
| Price | $6.33 | $15.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $9.38 | ★ $22.56 |
| AVG Volume (30 Days) | ★ 23.7M | 1.1M |
| Earning Date | 04-22-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | $1,827.70 | $10.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.90 | $10.65 |
| 52 Week High | $19.07 | $17.86 |
| Indicator | QS | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 36.94 | 62.54 |
| Support Level | $5.90 | $10.68 |
| Resistance Level | $7.21 | $15.74 |
| Average True Range (ATR) | 0.44 | 0.81 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 4.33 | 82.96 |
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional nodes. The company operates in one operating segment only.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.